# Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation

> **NCT04042272** · — · COMPLETED · sponsor: **Akdeniz University** · enrollment: 80 (actual)

## Conditions studied

- Kidney Transplant; Complications
- Neurologic Manifestations
- Uremic Encephalopathy

## Interventions

- **DIAGNOSTIC_TEST:** S100β, Neuron specific enolase (NSE) and Glial fibrillary acidic protein (GFAP)

## Key facts

- **NCT ID:** NCT04042272
- **Lead sponsor:** Akdeniz University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-15
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-01-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04042272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04042272, "Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04042272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*